The American Society of Radiologic Technologists has changed the focus and name of its 2008 annual meeting.
The American Society of Radiologic Technologists has changed the focus and name of its 2008 annual meeting.
The new name, the ASRT Annual Governance and House of Delegates Meeting, reflects the meeting's emphasis on practice issues, according to a release. The general education portion of the meeting will be eliminated. It will be held in Albuquerque, NM, June 13 to 15.
"Trying to combine a continuing education (CE) conference with a governance meeting meant that neither received the proper prominence or attention," said Cynthia Daniels, ASRT board chair. "The new meeting will allow us to focus on the important policy-making work of the house of delegates."
The ASRT will continue to host its annual Radiation Therapy Conference, which has always been a separate meeting from its annual conference.
For more information from the Diagnostic Imaging archives:
Imaging technologists enjoy continuing income growth
Physician extenders bolster productivity of practices
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.